[Quality of life evaluation in cancer patients to submitted to chemotherapy].
This descriptive and cross-sectional study aimed to assess the Quality of Life (QoL) of cancer patients who were receiving chemotherapy. The instrument European Organization for Research and Treatment of Cancer--Quality of Life Questionnaire Core-30 (EORTC QLQ-C30) was used for data collection. The sample consisted of 30 patients who signed the informed consent term. Data were analyzed in SPSS software. The QLQ-C30 showed that, for physical, cognitive and social functions, and role performance mean scores ranged from 71.26 to 75.12, demonstrating a satisfactory level. In the emotional function, the mean score was low (55.46). On the symptoms scales, there were a predominance of insomnia, with a mean score of 34.44, followed by pain 23.33 and fatigue 22.31. The QoL was satisfactory in all domains except for the emotional function, which scored low demonstrating that the collateral effects of chemotherapy exert a negative influence on patients' quality of life.
Sawada
Namie Okino
NO
Departamento de Enfermagem Geral e Especializada da Escola de Enfermagem de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, SP, Brasil. sawada@eerp.usp.br
Nicolussi
Adriana Cristina
AC
Okino
Liyoko
L
Cardozo
Fernanda Mara Coelho
FM
Zago
Marcia Maria Fontão
MM
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D003430:Cross-Sectional Studies; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000188:drug therapy*; D011788:Quality of Life